Sumitomo Mitsui Trust Group
TWST icon

Sumitomo Mitsui Trust Group’s Twist Bioscience TWST Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$103M Sell
1,000,344
-495,755
-33% -$32.3M 0.06% 294
2026
Q1 		$71.1M Sell
1,496,099
-406,730
-21% -$18.2M 0.05% 346
2025
Q4 		$60.4M Sell
1,902,829
-217,377
-10% -$6.78M 0.04% 410
2025
Q3 		$59.7M Sell
2,120,206
-179,231
-8% -$5.43M 0.03% 426
2025
Q2 		$84.6M Sell
2,299,437
-116,361
-5% -$4.02M 0.05% 327
2025
Q1 		$94.8M Sell
2,415,798
-197,166
-8% -$8.88M 0.07% 285
2024
Q4 		$121M Sell
2,612,964
-248,702
-9% -$11.2M 0.08% 232
2024
Q3 		$129M Sell
2,861,666
-301,765
-10% -$14.4M 0.09% 219
2024
Q2 		$156M Sell
3,163,431
-387,882
-11% -$15.8M 0.12% 177
2024
Q1 		$122M Sell
3,551,313
-32,130
-0.9% -$1.16M 0.08% 243
2023
Q4 		$132M Buy
3,583,443
+99,511
+3% +$2.3M 0.1% 214
2023
Q3 		$70.6M Sell
3,483,932
-82,307
-2% -$1.81M 0.06% 360
2023
Q2 		$73M Buy
3,566,239
+164,325
+5% +$2.46M 0.06% 367
2023
Q1 		$51.3M Buy
3,401,914
+467,881
+16% +$10.3M 0.04% 487
2022
Q4 		$69.9M Buy
2,934,033
+114,137
+4% +$3.31M 0.06% 395
2022
Q3 		$99.4M Buy
2,819,896
+142,726
+5% +$6.06M 0.08% 284
2022
Q2 		$93.6M Buy
2,677,170
+300,885
+13% +$10.7M 0.07% 314
2022
Q1 		$117M Buy
2,376,285
+25,028
+1% +$1.39M 0.08% 286
2021
Q4 		$182M Buy
2,351,257
+205,147
+10% +$21.1M 0.11% 199
2021
Q3 		$230M Sell
2,146,110
-381,800
-15% -$43.7M 0.14% 152
2021
Q2 		$337M Buy
2,527,910
+481,979
+24% +$56M 0.2% 116
2021
Q1 		$253M Buy
2,045,931
+195,214
+11% +$29.6M 0.16% 143
2020
Q4 		$261M Buy
1,850,717
+234,339
+14% +$26M 0.17% 134
2020
Q3 		$123M Buy
1,616,378
+639,384
+65% +$39.8M 0.08% 258
2020
Q2 		$44.3M Buy
976,994
+171,288
+21% +$6.15M 0.03% 528
2020
Q1 		$24.6M Buy
+805,706
New +$21.7M 0.02% 599

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Sumitomo Mitsui Trust Group's TWST Position: Q2 2026 in Review

Sumitomo Mitsui Trust Group reduced its Twist Bioscience (TWST) stake by 33% in Q2 2026, selling an estimated $32.3M and leaving 1,000,344 shares worth $103M. The position accounts for 0.06% of the portfolio, ranked #294.

Sumitomo Mitsui Trust Group first reported a position in TWST in Q1 2020 and has held it in 26 quarters since. The position peaked at $337M in Q2 2021. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Sumitomo Mitsui Trust Group held 1,000,344 shares of Twist Bioscience worth $103M as of Q2 2026.
  • Sumitomo Mitsui Trust Group sold 495,755 Twist Bioscience shares in Q2 2026, an estimated $32.3M.
  • Twist Bioscience made up 0.06% of Sumitomo Mitsui Trust Group's portfolio in Q2 2026, its #294 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Twist Bioscience in Q1 2020 and has held it in 26 quarters since.
  • Sumitomo Mitsui Trust Group's Twist Bioscience position peaked at $337M in Q2 2021.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2026, filed 30 Jul 2026.